PanGenex expects release of television program on Calci-CLEAR dietary supplement

PanGenex Corporation (Pink Sheets:PGCX) (“PanGenex” or “the Company”) announced today that it anticipates the release of its long form television program, demonstrating the benefits of Calci-CLEAR™, its patent pending dietary supplement that addresses soft tissue calcification, pursuant to its partnership with Incredible Discoveries® in early 2010.

Calci-CLEAR™ is a dietary supplement designed to address soft tissue calcification which is the abnormal hardening of soft tissues in the body such as tissues and organs, an important and pervasive condition affecting hundreds of millions of people worldwide.

“This program will allow the Company and its physician partners to reach a broad and diverse audience, an audience where an estimated 1 of every 5 adults has complications associated with soft tissue calcification,” stated Chairman John Stanton.